Kyorin Pharmaceutical Co.,ltd. Stock price
AI Insights on Kyorin Pharmaceutical Co.,ltd.
Insights
Is Kyorin Pharmaceutical Co.,ltd. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,100 stocks worldwide.
Key metrics
Kyorin Pharmaceutical Co.,ltd. Stock Analysis
Analyst Opinions
8 Analysts have issued a Kyorin Pharmaceutical Co.,ltd. forecast:
Analyst Opinions
8 Analysts have issued a Kyorin Pharmaceutical Co.,ltd. forecast:
Kyorin Pharmaceutical Co.,ltd. Events
Upcoming Event
Don't miss a Thing! We will send you all news about Kyorin Pharmaceutical Co.,ltd. directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Company Profile
KYORIN Pharmaceutical Co., Ltd. engages in the development, manufacture and sale of pharmaceutical products through its subsidiaries. The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 1,998 full-time employees. The company went IPO on 2006-03-10. The Pharmaceuticals segment is mainly engaged in the manufacture, purchase, sales and testing of pharmaceutical products, the purchase of raw materials for pharmaceuticals, the evaluation of technologies, the inspection, analysis and negotiation of license affiliations, the operations related to clinical trials and information gathering such as searching for drug discovery seeds, as well as the drug candidate compound discovery research and compound evaluation business. The firm also conducts the diagnostic businesses and verifies and creates research targets that are directly linked to drug discovery.
| Head office | Japan |
| CEO | Mr. Ogihara |
| Employees | 1,998 |
| Website | www.kyorin-pharm.co.jp |


